Anti-programmed Cell Death Protein-1 Therapy in Intrahepatic Cholangiocarcinoma Induced Type 1 Diabetes: A Case Report and Literature Review.

导出 LinkOut

翻译打印收藏纠错

第一作者： Zhi-Kai,Zheng

第一单位： Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.

作者： Zhi-Kai,Zheng ^[1] ; Jiong-Liang,Wang ^[2] ; Wen-Xuan,Li ^[1] ; Tian-Qing,Wu ^[2] ; Min-Shan,Chen ^[1] ; Zhong-Guo,Zhou ^[2]

作者单位： Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China. ^[1] Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangzhou, China. ^[2]

关键词 anti-programmed cell death protein-1 immune checkpoint inhibitors immune-related adverse events intrahepatic cholangiocarcinoma type 1 diabetes

主题词胆管肿瘤(Bile Duct Neoplasms);胆管, 肝内(Bile Ducts, Intrahepatic);细胞死亡(Cell Death);胆管上皮癌(Cholangiocarcinoma);糖尿病, 1型(Diabetes Mellitus, Type 1);女(雌)性(Female);人类(Humans);酮病(Ketosis);中年人(Middle Aged)

DOI 10.3389/fpubh.2022.917679

PMID 35784237

发布时间 2022-08-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in public health

2022年10卷

917679页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Anti-programmed Cell Death Protein-1 Therapy in Intrahepatic Cholangiocarcinoma Induced Type 1 Diabetes: A Case Report and Literature Review.

Frontiers in public health

相似文献

Frontiers in public health

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Anti-programmed Cell Death Protein-1 Therapy in Intrahepatic Cholangiocarcinoma Induced Type 1 Diabetes: A Case Report and Literature Review.

Frontiers in public health

相似文献

Frontiers in public health

相关期刊

检索历史清除